Drugs Made In America Acquisition II Corp. (DMII)
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Sector: Blank Checks
Industry: Financial - Conglomerates
Drugs Made In America Acquisition II Corp. Ordinary Shares
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 63.70M shares outstanding
USDrugs Made In America Acquisition II Corp. currently lacks significant business operations.
Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities.
The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
Leadership
Roger Bendelac
Chief Executive Officer
Saleem Elmasri
CFO & Principal Accounting Officer
Employees
2
Country
US
Sector
Financial Services
Website
dmaacorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Worman Glenn C. | CFO | Other | 100.0K | -- | Sep 26, 2025 |
 Stockwell Lynn | CEO and Exe. Chair of Board | Purchase | 700.0K | -- | Sep 26, 2025 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Other | 400.0K | -- | Sep 26, 2025 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Sale | 7.97M | -- | Sep 26, 2025 |
 Drugs Made In America Acquisition II LLC | 10% Owner | Purchase | 700.0K | -- | Sep 26, 2025 |
| Drugs Made In America Acquisition II LLC | 10% Owner | Other | 400.0K | -- | Sep 26, 2025 |
| Name | Shares | % | Source |
|---|---|---|---|
Drugs Made In America Acquisition II LLC · filed Oct 2025 | 6.0M+700.0K via derivatives | 10.5% | 13D |
Karpus Management, Inc. | 2.8M | 4.4% | 13F |
Magnetar Financial LLC | 2.7M | 4.2% | 13F |
MMCAP International Inc. SPC | 2.7M | 4.2% | 13F |
GLAZER CAPITAL, LLC | 2.3M | 3.7% | 13F |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2.2M | 3.5% | 13F |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND DMIIR | 2.0M | -- | 13F |
LMR Partners LLP DMIIU | 2.0M | -- | 13F |
MILLENNIUM MANAGEMENT LLC | 2.0M | 3.1% | 13F |
Hudson Bay Capital Management LP | 2.0M | 3.1% | 13F |
Insiders
- Worman Glenn C.CFO
- Stockwell LynnCEO and Exe. Chair of Board
- Drugs Made In America Acquisition II LLC10% Owner
- Do CatherineDirector
- Shulgan Myron W.Director
- Prasad Sridhar G.Director
based on 63.70M shares outstanding
US30d Avg
249.97K
60d Avg
151.53K
90d Avg
132.30K